To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video After FLT3m+ AML Has Turned Your Life Upside Down XOSPATA is the only FDA-approved targeted therapy for people with FLT3m+ AML when the disease has come back or has not improved after previous treatment AML=acute myeloid leukemia; FDA=Food and Drug Administration; FLT3=FMS-like tyrosine kinase 3; m+=mutation-positive.
Patient Stories: Having Hope A real XOSPATA patient talks about the importance of staying positive and having a strong support system. To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video SEE MORE FROM RAY'S XOSPATA JOURNEY The patient featured in this video is taking or has taken XOSPATA. The patient was compensated by Astellas to share his story. Results may vary. Talk with your doctor about what this may mean for you.